MAKING NEWBORN SCREENING MORE ACCESSIBLE WITH TECH

Wouldn't it be great if all genetic disorders could be detected early, especially the ones that can be treated? Yet, many aren't tested for because it's expensive and needs fancy equipment. Enter SCAN: a new, affordable way to check for common aneuploidies using nanopore sequencing. SCAN first amplifies, then tags (barcodes) DNA. It then sequences these tagged bits with nanopores and uses machine learning to predict outcomes. This combo makes SCAN a game-changer! A test for Klinefelter Syndrome proved its worth, hitting 100% on the mark for accuracy, sensitivity, and specificity. It's the first global IVD-certified genetic test using nanopore tech. The best part? This approach could soon help spot other aneuploidies too, making newborn screening more accessible and effective. You can't help but wonder, what's next on the horizon for early detection?